Heron Therapeutics, Inc. (HRTX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 5.37 |
| Open | 5.36 |
| Bid | 0.00 x 3000 |
| Ask | 0.00 x 3000 |
| Day's range | 4.93 - 5.62 |
| 52-week range | 2.19 - 12.89 |
| Volume | |
| Avg. volume | 3,004,106 |
| Market cap | 637.747M |
| Beta (5Y monthly) | 1.33 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.29 |
| Earnings date | 01 Nov 2022 - 07 Nov 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 15.08 |
- Zacks
How Much Upside is Left in Heron Therapeutics (HRTX)? Wall Street Analysts Think 91%
The average of price targets set by Wall Street analysts indicates a potential upside of 90.6% in Heron Therapeutics (HRTX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
- Zacks
Heron Therapeutics (HRTX) Reports Q2 Loss, Tops Revenue Estimates
Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -10% and 11.98%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Heron Therapeutics (NASDAQ:HRTX) shareholders have endured a 83% loss from investing in the stock three years ago
Heron Therapeutics, Inc. ( NASDAQ:HRTX ) shareholders should be happy to see the share price up 12% in the last month...
© 2022 Yahoo. All rights reserved.
